Arbutus Biopharma Corporation (ABUS): Scroll down to Providence Therapeutics t...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Arbutus Biopharma Corporation (ABUS)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	65
Posts	4805
Boards Moderated	0
Alias Born	08/08/2008

Re: Purple Wonder post# 6218

Monday, 12/28/2020 9:25:03 AM

Monday, December 28, 2020 9:25:03 AM

Scroll down to Providence Therapeutics to learn more about their Covid-19 vaccine candidate. The most interesting part for me is:

The mRNA sequence, which is manufactured at Providence's Toronto plant, will be packaged in microscopic containers called lipid nanoparticles (LNPs) for injection into the body. The LNPs are made by Vancouver-based Genevant and are already used in an approved mRNA-based medication.

https://www.cbc.ca/news/technology/canadian-vaccine-candidates-covid-coronavirus-1.5764874

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ABUS News

Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/15/2025 08:27:18 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/04/2025 08:06:26 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/04/2025 08:05:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2025 08:11:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2025 08:24:03 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2025 08:21:38 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2025 01:42:31 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/27/2025 11:31:42 AM
Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2025 11:31:09 AM
Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/27/2025 11:30:00 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/24/2025 01:19:08 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2025 08:14:12 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2025 08:08:32 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/19/2025 01:34:51 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/13/2025 07:55:34 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2025 07:59:31 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 09:13:29 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 09:11:44 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 09:08:38 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2025 09:07:01 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2025 02:24:59 PM
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna • GlobeNewswire Inc. • 03/03/2025 02:15:09 PM
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna • GlobeNewswire Inc. • 03/03/2025 02:15:00 PM
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/25/2025 12:19:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2025 12:05:12 PM

More ABUS News

InvestorsHub NewsWire

VAYK Corrects Major Clerical Error to Report $668K Operating Revenue for 2024 • VAYK • Apr 17, 2025 9:00 AM

UAV Corp Names David Dugas as President and Chief Operating Officer • UMAV • Apr 17, 2025 8:30 AM

Yuengling's Ice Cream Corporation (OTC: YCRM), Doing Business as ReachOut, Files 2024 10-K With Profitability, Growth, and Corporate Transformation in Focus • YCRM • Apr 16, 2025 11:07 AM

Avant Technologies and JV Partner, Ainnova, Accelerate Expansion Across Latin America Following Key Role at Healthcare Innovation Summit • AVAI • Apr 16, 2025 8:00 AM

HealthLynked Welcomes Anthony Scuilla as Sales Consultant to Drive Strategic Partnerships with Insurance Providers • HLYK • Apr 14, 2025 8:00 AM

Glidelogic Corp. Partners with Sunwah Global Youth Innovation Center • GDLG • Apr 10, 2025 4:00 PM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow